Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: Can we assure the safety of the fetus?

References

• Center for Substance Abuse Treatment. Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment Improvement Protocol Series 43 Rockville, Md: US Department of Health and human Services 2005.
   Google Scholar
• Dashe JS, Jackson GL, Olscher DA, Zane EH, Wendel GD Jr. Opioid detoxification in pregnancy. Obstet Gynecol 1998;92:854–858.
   PubMed Web of Science ®Google Scholar
• Lim S, Prasad MR, Samuels P, Gardner DK, Cordero L. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. Am J Obstet Gynecol 2009;200:70.e1–70.e5.
   Web of Science ®Google Scholar
• Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O’Grady KE, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010;363:2320–2331.
   PubMed Web of Science ®Google Scholar
• Stevenson DK, Sunshine P, Benitz WE. Fetal and Neonatal Brain Injury. Cambridge University Press, 3rd Edition 2005, p287.
   Google Scholar
• Kenner, C, Lott JW. Comprehensive Neonatal Care: An Interdisciplinary Approach. Saunders 2007, p 426.
   Google Scholar
• Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975;2:141–158.
   PubMedGoogle Scholar
• Umans JG, Szeto HH. Precipitated opiate abstinence in utero. Am J Obstet Gynecol 1985;151:441–444.
   PubMed Web of Science ®Google Scholar
• Lichtblau L, Sparber SB. Opiate withdrawal in utero increases neonatal morbidity in the rat. Science 1981;212:943–945.
   PubMedGoogle Scholar
• Schrott LM, Baumgart MI, Zhang X, Sparber SB. Prenatal opiate withdrawal activates the chick embryo hypothalamic pituitary-adrenal axis and dilates vitelline blood vessels via serotonin(2) receptors. J Pharmacol Exp Ther 2002;303:257–264.
   PubMedGoogle Scholar
• Wong WM, Lao TT. Abnormal umbilical artery flow velocity waveform–a sign of fetal narcotic withdrawal? Aust N Z J Obstet Gynaecol 1997;37:358–359.
   PubMedGoogle Scholar
• Rementeriá JL, Nunag NN. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynecol 1973;116:1152–1156.
   PubMed Web of Science ®Google Scholar
• Fricker HS, Segal S. Narcotic addiction, pregnancy, and the newborn. Am J Dis Child 1978;132:360–366.
   PubMedGoogle Scholar
• Zuspan FP, Gumpel JA, Mejia-Zelaya A, Madden J, Davis R. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975;122:43–46.
   PubMed Web of Science ®Google Scholar
• Barker DJ, Hanson MA. Altered regional blood flow in the fetus: the origins of cardiovascular disease? Acta Paediatr 2004;93:1559–1560.
   PubMed Web of Science ®Google Scholar
• Salisbury AL, Ponder KL, Padbury JF, Lester BM. Fetal effects of psychoactive drugs. Clin Perinatol 2009;36:595–619.
   PubMed Web of Science ®Google Scholar
• Pollard I. Neuropharmacology of drugs and alcohol in mother and fetus. Semin Fetal Neonatal Med 2007;12:106–113.
   PubMed Web of Science ®Google Scholar
• Blinick G, Wallach RC, Jerez E. Pregnancy in narcotics addicts treated by medical withdrawal. The methadone detoxification program. Am J Obstet Gynecol 1969;105:997–1003.
   PubMed Web of Science ®Google Scholar
• Mello NK, Mendelson JH. Buprenorphine suppresses heroin use by heroin addicts. Science 1980;207:657–659.
   PubMed Web of Science ®Google Scholar
• Jones HE, Johnson RE, Jasinski DR, Milio L. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Drug Alcohol Depend 2005;78:33–38.
   PubMed Web of Science ®Google Scholar
• Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, Aschauer H. Methadone versus buprenorphine in pregnant addicts: a double blind, double-dummy comparison study. Addiction 2006;101:275–281.
   PubMed Web of Science ®Google Scholar
• Jones HE, Suess P, Jasinski DR, Johnson RE. Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study. Am J Addict 2006;15:61–70.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2008: CD002207.
   PubMed Web of Science ®Google Scholar
• Fischer G, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, Langer M et al. Treatment of opioid dependent women with buprenorphine. Addiction 2000;95:239–44.
   PubMed Web of Science ®Google Scholar
• Nijhuis JG. Fetal behavior. Neurobiol Aging 2003;24 Suppl 1:S41–6; discussion S47.
   PubMedGoogle Scholar
• Newman RG. Response to “transferring methadone-stabilized pregnant patients to buprenorphine”. Am J Addict 2006;15:400; author reply 401–400; author reply 402.
   PubMedGoogle Scholar
• Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Eur Addict Res 2009;15:128–134.
   PubMed Web of Science ®Google Scholar
• Luty J, Nikolaou V, Bearn J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat 2003;24:363–367.
   PubMed Web of Science ®Google Scholar